Literature DB >> 24652220

[Design of a multicolor panel to assess intracellular and surface molecules by flow cytometry].

Jose Mateus1, Paola Lasso2, John Mario González3, Concepción Judith Puerta2, Adriana Cuéllar1.   

Abstract

INTRODUCTION: Flow cytometry allows simultaneous detection of surface and intracellular molecules on each cell.
OBJECTIVE: To describe a method for building up a harmonic multicolor panel with 11 flow cytometry parameters for phenotypic and functional analysis on CD8 + T lymphocytes.
MATERIALS AND METHODS: For the multicolor panel construction, we selected the molecules and titred conjugated antibodies with fluorochromes for CD3, CD8, CCR7, CD28, CD27, CD45RA, CD95 and CD127 determination in peripheral blood mononuclear cells (PBMC). To evaluate the panel, the conjugated antibodies were gradually added one by one and fluorescence minus one (FMO) test was performed. This method was applied to assess ex vivo subpopulations of T cells and the production of intracellular IFN ? , IL-2 and TNF a using polyclonal stimulation with enterotoxin B from Staphylococcus aureus (SEB) and antigen-specific cells with crude Trypanosoma cruzi antigen. Finally, the ex vivo CD8 + T lymphocyte subpopulations frequencies were analyzed in healthy individuals.
RESULTS: The evaluation of the selected molecules and conjugates did not show interference in the fluorescence signals and detection. The frequencies of CD8 + T cells evaluated were similar to the values reported in other studies. Additionally, we observed that the frequency of CD8 + T lymphocytes producing IFN ? , IL-2 and TNF a was higher 6 hours after culture with SEB and crude T. cruzi lysate.
CONCLUSIONS: The method used for the construction of a multicolor panel allows obtaining frequencies of CD8 + T lymphocyte subpopulations corresponding to those reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24652220     DOI: 10.7705/biomedica.v33i4.1709

Source DB:  PubMed          Journal:  Biomedica        ISSN: 0120-4157            Impact factor:   0.935


  6 in total

1.  Low frequency of circulating CD8+ T stem cell memory cells in chronic chagasic patients with severe forms of the disease.

Authors:  Jose Mateus; Paola Lasso; Paula Pavia; Fernando Rosas; Nubia Roa; Carlos Andrés Valencia-Hernández; John Mario González; Concepción J Puerta; Adriana Cuéllar
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

2.  Expression of inhibitory receptors and polyfunctional responses of T cells are linked to the risk of congenital transmission of T. cruzi.

Authors:  Adriana Egui; Paola Lasso; María Carmen Thomas; Bartolomé Carrilero; John Mario González; Adriana Cuéllar; Manuel Segovia; Concepción Judith Puerta; Manuel Carlos López
Journal:  PLoS Negl Trop Dis       Date:  2017-06-09

3.  An Animal Model of Acute and Chronic Chagas Disease With the Reticulotropic Y Strain of Trypanosoma cruzi That Depicts the Multifunctionality and Dysfunctionality of T Cells.

Authors:  Jose Mateus; Paula Guerrero; Paola Lasso; Claudia Cuervo; John Mario González; Concepción J Puerta; Adriana Cuéllar
Journal:  Front Immunol       Date:  2019-04-26       Impact factor: 7.561

4.  A proportion of CD4+ T cells from patients with chronic Chagas disease undergo a dysfunctional process, which is partially reversed by benznidazole treatment.

Authors:  Elena Pérez-Antón; Adriana Egui; M Carmen Thomas; Bartolomé Carrilero; Marina Simón; Miguel Ángel López-Ruz; Manuel Segovia; Manuel Carlos López
Journal:  PLoS Negl Trop Dis       Date:  2021-02-04

5.  A terpenoid-rich extract from Clethra fimbriata exhibits anti-Trypanosoma cru zi activity and induces T cell cytokine production.

Authors:  Daniel Pardo-Rodriguez; Paola Lasso; José Mateus; John Mendez; Concepción J Puerta; Adriana Cuéllar; Jorge Robles; Claudia Cuervo
Journal:  Heliyon       Date:  2022-03-25

6.  Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.

Authors:  Elena Pérez-Antón; Adriana Egui; M Carmen Thomas; Concepción J Puerta; John Mario González; Adriana Cuéllar; Manuel Segovia; Manuel Carlos López
Journal:  PLoS Negl Trop Dis       Date:  2018-05-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.